memantine has been researched along with Dyskinesia, Drug-Induced in 7 studies
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Memantine was well tolerated, without any serious adverse events, or worsening in the parkinsonian motor score." | 2.82 | Memantine and reduced time with dyskinesia in Parkinson's Disease. ( Wictorin, K; Widner, H, 2016) |
| "Memantine treatment was associated with lower axial motor symptom and dyskinesia scores but did not improve gait." | 2.78 | Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study. ( Allorge, D; Blum, D; Bordet, R; Defebvre, L; Delval, A; Destée, A; Devos, D; Duhamel, A; Dujardin, K; Hossein-Foucher, C; Moreau, C; Petyt, G; Sablonnière, B; Schraen, S; Tiffreau, V, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wictorin, K | 1 |
| Widner, H | 1 |
| Varanese, S | 1 |
| Howard, J | 1 |
| Di Rocco, A | 1 |
| Moreau, C | 1 |
| Delval, A | 1 |
| Tiffreau, V | 1 |
| Defebvre, L | 1 |
| Dujardin, K | 1 |
| Duhamel, A | 1 |
| Petyt, G | 1 |
| Hossein-Foucher, C | 1 |
| Blum, D | 1 |
| Sablonnière, B | 1 |
| Schraen, S | 1 |
| Allorge, D | 1 |
| Destée, A | 1 |
| Bordet, R | 1 |
| Devos, D | 1 |
| Vidal, EI | 1 |
| Fukushima, FB | 1 |
| Valle, AP | 1 |
| Villas Boas, PJ | 1 |
| Andreassen, OA | 1 |
| Waage, J | 1 |
| Finsen, B | 1 |
| Jørgensen, HA | 1 |
| Wesemann, W | 1 |
| Sontag, KH | 1 |
| Maj, J | 1 |
| Hanağasi, HA | 1 |
| Kaptanoglu, G | 1 |
| Sahin, HA | 1 |
| Emre, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Study of Memantine to Treat Gait Disorders And Attention Deficit In Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Monocentric Trial[NCT01108029] | Phase 4 | 28 participants (Actual) | Interventional | 2009-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for memantine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
[Pharmacodynamics and pharmacokinetics of memantine].
Topics: Amantadine; Animals; Antidepressive Agents; Body Temperature; Catalepsy; Dopamine; Dyskinesia, Drug- | 1983 |
2 trials available for memantine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Memantine and reduced time with dyskinesia in Parkinson's Disease.
Topics: Aged; Antiparkinson Agents; Cross-Over Studies; Double-Blind Method; Dyskinesia, Drug-Induced; Excit | 2016 |
Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Disability Evaluation; Double-Blind Method; Dyskinesi | 2013 |
4 other studies available for memantine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
NMDA antagonist memantine improves levodopa-induced dyskinesias and "on-off" phenomena in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Humans; Incidence; Le | 2010 |
Unexpected improvement in levodopa-induced dyskinesia and on-off phenomena after introduction of memantine for treatment of Parkinson's disease dementia.
Topics: Aged, 80 and over; Antiparkinson Agents; Dementia; Dopamine Agents; Dyskinesia, Drug-Induced; Humans | 2013 |
Memantine attenuates the increase in striatal preproenkephalin mRNA expression and development of haloperidol-induced persistent oral dyskinesias in rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cell Count; Corpus Striatum; Dopamine Antagonists; | 2003 |
The use of NMDA antagonist memantine in drug-resistant dyskinesias resulting from L-dopa.
Topics: Adult; Antiparkinson Agents; Dopamine Agents; Dose-Response Relationship, Drug; Drug Therapy, Combin | 2000 |